Amadeus Capital Partners

Portfolio Co Investors 2026 for Amadeus Capital Partners: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Amadeus Capital Partners accounts for 16 tracked companies with verified cap-table data, 16 of which disclose round sizes totalling $1.8B. The median disclosed raise is $59M, and the largest is Improbable at $902M, ahead of Nuclera ($145M) and Warren Brasil ($100M).

The names that recur most often on these co-invested cap tables are Amadeus Capital Partners (16 companies), Cambridge Innovation Capital (3 companies), IQ Capital (3 companies), British Patient Capital (2 companies), Ahren Innovation Capital (2 companies), University of Cambridge (2 companies). By latest disclosed round, the market skews Series C (5), Series A (5), Series B (2), Other Equity (1).

Best funded Amadeus Capital Partners companies

  1. Improbable — $902M (latest: Other Equity)
  2. Nuclera — $145M (latest: Series C)
  3. Warren Brasil — $100M (latest: Series C)
  4. Congenica — $82M (latest: Series C)
  5. Constructive Bio — $75M (latest: Series A)
  6. Nu Quantum — $75M (latest: Series A)
  7. Speechmatics — $70M (latest: Series B)
  8. USound — $59M (latest: Series U)
  9. Paragraf — $55M (latest: Series C)
  10. The Helper Bees — $54M (latest: Series C)
  11. OrganOx — $54M (latest: Growth)
  12. V7 — $43M (latest: Series A)
  13. Riverlane — $40M
  14. Quibim — $22M (latest: Series A)
  15. Sphere Fluidics — $18M (latest: Series A)

Amadeus Capital Partners — related firms and companies (56)

Amadeus Capital Partners profile · All research reports